Role of endogenous vitamin e in renal ischemic preconditioning process: Differences between male and female rats

Iranian Biomedical Journal

Volumn 16, Issue 1, 2012, Pages 44-51

  Aryamanesh, Simin ^a   Ebrahimi, Seyyed Meisam ^b   Abotaleb, Nahid ^c   Nobakht, Maliheh ^c,d   Rahimi Moghaddam, Parvaneh ^c  

^a Tehran Forensic Medicine   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

tocopherol; carotene; Antioxidant; Ischemic preconditioning (IPC); Reperfusion

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CREATININE; RETINOL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOCAL GLOMERULONEPHRITIS; GLOMERULUS; HISTOPATHOLOGY; ISCHEMIC PRECONDITIONING; KIDNEY ISCHEMIA; KIDNEY TUBULE; MALE; NONHUMAN; RAT; RENAL PROTECTION; REPERFUSION INJURY; SEX DIFFERENCE; UREA NITROGEN BLOOD LEVEL; VITAMIN BLOOD LEVEL; ANIMAL; BLOOD; COMPARATIVE STUDY; ISCHEMIA; KIDNEY; METABOLISM; METHODOLOGY; PATHOLOGY; RANDOMIZATION; RENAL ARTERY; SEXUAL DEVELOPMENT; VASCULARIZATION; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BLOOD UREA NITROGEN; FEMALE; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RENAL ARTERY; REPERFUSION INJURY; SEX CHARACTERISTICS; VITAMIN A; VITAMIN E;

EID: 84866461881     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/IBJ.983.2012     Document Type: Article

References (30)

1. Molitoris BA. Ischemic acute renal failure: Exciting times at our fingertips (editorial). Curr Opin Nephrol Hypertens. 1998 Jul;7(4):405-6.
2. Zhao JL, Yang YJ, Cui CJ, You SJ, Gao RL. Pretreatment with simvastatin reduces myocardial noreflow by opening mitochondrial K (ATP) channel. Br J Pharmacol. 2006 Oct;149(3):243-9.
3. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004 Nov;364 (9447):1814-27.
4. Yokota N, O'Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B et al. Protective effect of HMGCoA reductase inhibitor on experimental renal ischemiareperfusion injury. Am J Nephrol. 2003 Jan-Feb;23(1):13-7.
5. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens. 2002 Jan;11(1):43-8.
6. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a metaanalysis. J Am Soc Nephrol. 2000 Feb;11(2):319-29.
7. Muller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G. Sexual dimorphism in renal ischemiareperfusion injury in rats: Possible role of endothelin. Kidney Int. 2002 Oct;62(4):1364-71.
8. Torras J, Herrero-Fresneda I, Lioberas N, Riera M, Ma Cruzado J, Ma Grinyo J. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 2002 Jun;61(6):2218-27.
9. Bieri JG, Tolliver TJ. On the occurrence of alphatocopherolquinone in rat tissue. Lipids. 1981 Oct;16(10):777-9.
10. Pitcher JM, Wang M, Tsai BM, Kher A, Turrentine MW, Brown JW et al. Preconditioning: Gender Effects. J Surg Res. 2005 Dec;129(2):202-20.
11. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischemic preconditioning and ischemia-reperfusion injury in mice. Acta Physiol Scand. 2003 Apr;177(4):459-66.
12. Hale SL, Birnbaum Y, Kloner RA. β-estradiol, but not α-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart. J. 1996;132:258-62.
13. Kim YD, Chen B, Beauregard J, Kouretas P, Thomas G, Farhat MY et al. 17 β-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemiareperfusion. Circulation. 1996;94:2901-8.
14. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V et al. The involvement of tumor necrosis factor-α in the protective effects of 17 β-oestradiol in splanchnic ischemia-reperfusion injury. Br J Pharmacol. 1997 Aug;121(8):1782-8.
15. Gasbarrini A, Addolorato G, Di Campli C, Simoncini M, Montemagno S, Castagneto M, et al. Gender affects reperfusion injury in rat liver. Dig Dis Sci. 2001 Jun;46(6):1305-12.
16. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5(Suppl 1):S3-10.
17. Kher A, Meldrum KK, Wang M, Tsai BM., Pitcher JM. Meldrum DR. Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res. 2005 Sep;67(4):594-603.
18. Oldenburg O, Qin Q, Krieg T, Yang XM., Philipp S, Critz SD. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H468-76.
19. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001 Nov;52(2): 181-98.
20. Patel HH, Hsu A, Moore J, Gross GJ. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol. 2001 Aug;33(8):1455-65.
21. Skyschally A, schulz R, Gres P, Korth H, Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H698-703.
22. Ingold KU, Webb AC, Witter D, Burton GW, Metcalfe TA, Muller DP. Vitamin E remains the major lipidsoluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys. 1987 Nov;259(1):224-5.
23. Andreadou I, Iliodromitis EK, Tsovolas K, Aggeli IK, Zoga A, Gaitanaki C et al. Acute administration of vitamin E triggers preconditioning via K(ATP) channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med. 2006 Oct;41(7):1092-9.
24. Ricciarelli R, Zingg J, Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J. 2001 Nov;15(13):2314-25.
25. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr. 2002 Oct;76(4):703-16.
26. Rimbach G, Minihane AM, Majewicz J, Fischer A, Pallauf J, Virgli F et al. Regulation of cell signaling by vitamin E. Proc Nutr Soc. 2002;61:415-25.
27. Car AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alphatocopherol (vitamin E). Circ Res. 2000 Sep;87(5):349-54.
28. Muzakova V, Kandar R, Vojtisek P, Skalicky J, Vankova R, Cegan A. Antioxidant vitamin levels and glutathione peroxidase activity during ischemiareperfusion in myocardial infarction. Physiol Res. 2001;50(4): 389-96.
29. Charniot JC, Vignat N, Albertini JP, Bogdanova V, Zerhouni K, Monsuez JJ et al. Oxidative stress in patients with acute heart failure. Rejuvenation Res. 2008 Apr;11(2):393-8.
30. Kadkhodaee M, Aryamanesh S, Faghihi M, Zahmatkesh M. Protection of rat renal vitamin E levels by ischemicpreconditioning. BMC Nephrol. 2004 Apr;5:6-13.